Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BECK TERESA
Last Updated 
20-Nov-09
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BECK TERESA: Declared Holdings
Company/RelationshipReportedShares  Ownership
Amylin Pharmaceuticals, Inc.
Director
NasdaqGS:AMLN
(historical quotes, profile, SEC, other insiders)
11-Dec-075,000  Direct
LEXMARK INTL INC
Director
NYSE:LXK
(historical quotes, profile, SEC, other insiders)
30-Jun-098,719  Direct
QUESTAR CP
Director
NYSE:STR
(historical quotes, profile, SEC, other insiders)
9-Nov-094,055  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
9-Nov-09 12,800STR Sale at $42.26 per share.
(Proceeds of $540,928)
3-Nov-09 12,800STR Option Exercise at $7.50 per share.
(Cost of $96,000)
14-Sep-09 0STR Acquisition (Non Open Market) at $35.25 per share.
(Value of $0)
30-Jun-09 583LXK Option Exercise at $0 per share.
15-Jun-09 0STR Acquisition (Non Open Market) at $35.21 per share.
(Value of $0)
23-Apr-09 5,559LXK Acquisition (Non Open Market) at $0 per share.
16-Mar-09 0STR Acquisition (Non Open Market) at $28.04 per share.
(Value of $0)
15-Dec-08 0STR Acquisition (Non Open Market) at $32.09 per share.
(Value of $0)
30-Jun-08 477LXK Option Exercise at $0 per share.
10-Mar-08 7STR Acquisition (Non Open Market) at $55.77 per share.
(Value of $390)
11-Dec-07 5,000AMLN Acquisition (Non Open Market) at $38.52 per share.
(Value of $192,600)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?